Free Trial

DocGo (DCGO) Competitors

DocGo logo
$1.28 -0.11 (-7.91%)
Closing price 04:00 PM Eastern
Extended Trading
$1.32 +0.04 (+3.52%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DCGO vs. EHAB, TALK, AUNA, INNV, CSTL, FTRE, PSNL, CELC, LFMD, and SBC

Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Enhabit (EHAB), Talkspace (TALK), Auna (AUNA), InnovAge (INNV), Castle Biosciences (CSTL), Fortrea (FTRE), Personalis (PSNL), Celcuity (CELC), LifeMD (LFMD), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry.

DocGo vs.

Enhabit (NYSE:EHAB) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations.

In the previous week, Enhabit and Enhabit both had 15 articles in the media. Enhabit's average media sentiment score of 1.32 beat DocGo's score of 0.75 indicating that Enhabit is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Enhabit
10 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DocGo
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

56.4% of DocGo shares are held by institutional investors. 1.9% of Enhabit shares are held by insiders. Comparatively, 2.7% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Enhabit presently has a consensus target price of $8.50, suggesting a potential downside of 18.32%. DocGo has a consensus target price of $3.56, suggesting a potential upside of 168.68%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than Enhabit.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enhabit
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
DocGo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

DocGo has a net margin of 4.35% compared to Enhabit's net margin of -11.24%. DocGo's return on equity of 8.90% beat Enhabit's return on equity.

Company Net Margins Return on Equity Return on Assets
Enhabit-11.24% 1.67% 0.80%
DocGo 4.35%8.90%5.72%

DocGo received 44 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 73.13% of users gave DocGo an outperform vote while only 17.24% of users gave Enhabit an outperform vote.

CompanyUnderperformOutperform
EnhabitOutperform Votes
5
17.24%
Underperform Votes
24
82.76%
DocGoOutperform Votes
49
73.13%
Underperform Votes
18
26.87%

Enhabit has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, DocGo has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.

DocGo has lower revenue, but higher earnings than Enhabit. DocGo is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enhabit$1.03B0.51-$80.50M-$2.77-3.76
DocGo$520.50M0.26$6.86M-$0.02-66.25

Summary

DocGo beats Enhabit on 13 of the 17 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DCGO vs. The Competition

MetricDocGoHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$135.13M$845.61M$5.40B$8.53B
Dividend YieldN/A2.30%5.22%4.11%
P/E Ratio4.7353.7826.7419.97
Price / Sales0.2610.41394.93122.22
Price / Cash23.6226.1438.2534.62
Price / Book0.453.926.874.59
Net Income$6.86M-$5.50M$3.23B$248.18M
7 Day Performance-5.36%7.77%5.01%2.15%
1 Month Performance-35.99%71.62%12.82%16.14%
1 Year Performance-55.98%19.22%17.63%8.06%

DocGo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DCGO
DocGo
3.6871 of 5 stars
$1.28
-7.9%
$3.56
+178.1%
-54.3%$130.54M$520.50M4.572,920
EHAB
Enhabit
2.0795 of 5 stars
$10.44
+1.5%
$8.50
-18.5%
+18.1%$528.40M$1.03B-4.5010,900News Coverage
Positive News
Gap Up
TALK
Talkspace
3.7509 of 5 stars
$3.08
+2.0%
$4.50
+46.1%
+7.1%$518.79M$194.36M308.31500Positive News
AUNA
Auna
3.6725 of 5 stars
$6.96
+1.4%
$13.50
+94.1%
-17.0%$514.46M$4.39B18.3014,958News Coverage
Earnings Report
INNV
InnovAge
1.0504 of 5 stars
$3.80
+4.4%
$5.00
+31.6%
-1.6%$513.93M$806.61M-20.002,000Gap Up
CSTL
Castle Biosciences
3.0542 of 5 stars
$17.04
+1.5%
$37.50
+120.1%
-33.8%$491.98M$347.08M85.20540News Coverage
Analyst Forecast
Gap Up
FTRE
Fortrea
3.4043 of 5 stars
$5.19
-15.6%
$15.82
+204.8%
-82.6%$469.90M$2.70B-1.5218,000Gap Down
High Trading Volume
PSNL
Personalis
4.3611 of 5 stars
$5.10
+1.2%
$8.00
+56.9%
+239.7%$450.37M$84.61M-3.04400News Coverage
CELC
Celcuity
2.1205 of 5 stars
$10.68
+5.2%
$30.17
+182.5%
-36.6%$404.12MN/A-4.0940Trending News
Earnings Report
Analyst Forecast
Analyst Revision
LFMD
LifeMD
1.2695 of 5 stars
$8.55
+3.5%
$11.00
+28.7%
+34.7%$388.58M$234.01M-13.36230Gap Down
SBC
SBC Medical Group
N/A$3.46
+3.9%
N/AN/A$358.49M$205.42M0.00N/AEarnings Report
Analyst Revision

Related Companies and Tools


This page (NASDAQ:DCGO) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners